Cassava Sciences | PTIE - Trade Debtors


Cassava Sciences reported $117K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 117K 3K Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Geron USD 39.23M 1.57M Dec/2025
J&J USD 22.54B 1.21B Mar/2026
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025